Vanguard finally built a T-bill ETF to challenge the category king, and the fee story is not as simple as Vanguard fans expect. The real tiebreaker has nothing to do with basis points.
By Jake FitzGerald
· 9:30pm ET Ethereum (CRYPTO:ETH) is trading at $2,603, reflecting a 6.43% increase over the past 24 hours and a 10.6% rise above its September low, which had briefly suggested a potential breakdown. The support…
Sam Daodu Stablecoin rewards are payments for holding dollar-pegged tokens, similar to interest on savings accounts. These payments continued even after the CLARITY Act, which aimed to limit them, failed in the Senate on…
Producing one Bitcoin (CRYPTO:BTC) costs approximately $78,000, according to JPMorgan. The price of Bitcoin remained below this production cost for five consecutive months up to June 2026. This situation creates financial strain…
Sam Daodu When Social Security falls short every single month, the account you tap first changes everything, and most retirees get that order wrong before they ever pick an investment.
Five hundred thousand dollars just landed in your account, and the decision you make in the next few days will shape your returns for the next two decades. The math and your nervous system…
QQQI's monthly distributions look generous on paper, but the IRS filings and total return math tell a story most holders never see before they reinvest their next payment.
A seven-figure VOO balance sounds like a retirement paycheck until you do the actual math on what it deposits each month, then realize covering the rest means a tax bill your fund prospectus quietly…
VYM has been one of the most trusted dividend ETFs for years, but a smaller BlackRock rival built on a completely different rulebook has quietly pulled far ahead in 2026, and the yield gap…
BlackRock's popular international dividend ETF has a loyal following, but a quieter Fidelity rival has been keeping pace on returns while charging investors a fee that is less than half the price. The case…
Eli Lilly stakes its trillion-dollar valuation on mid-stage data for a two-drug obesity combo, and the September 30 readout will reveal whether eloraTZP is a genuine franchise leap or an expensive gamble on incremental…
Most covered call ETFs hand you a fat monthly check while quietly draining your principal, but a small group of actively managed funds has cracked the formula to deliver both. The catch is that…
